Evidence map›Paper›PMID 19186999›Full record

ArticleAntioxidants & redox signaling2009

Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis.

Achuthan Raghavamenon, Mahdi Garelnabi, Sainath Babu, Alex Aldrich, Dmitry Litvinov, Sampath Parthasarathy

Open access · greenAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Characterization of fecal metabolome changes in patients with obstructive sleep apnea.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Achuthan RaghavamenonDepartment of Environmental Toxicology, Southern University and A&M College, Baton Rouge, Louisiana, USA.
Mahdi Garelnabi
Sainath Babu
Alex Aldrich
Dmitry Litvinov
Sampath Parthasarathy
The Ohio State University · US

Funding

Oxidation Hypothesis--Paradoxes and PitfallsR01HL069038 · NHLBI · OHIO STATE UNIVERSITY · PI PARTHASARATHY, SAMPATH · 2002 to 2006
$1.8M
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSISR01DK056353 · NIDDK · OHIO STATE UNIVERSITY · PI PARTHASARATHY, SAMPATH · 2000 to 2004
$1.6M
NHLBI NIH HHS HL69038NIDDK NIH HHS DK056353
6 · The paper itself

Abstract

The decomposition of peroxidized lipids of low-density lipoprotein (LDL) has been suggested to be involved in atherosclerosis. In this study, an in vitro system with 13-hydroperoxylinoleic acid (13-HPODE) was used to determine the effects of antioxidants on its decomposition. Decomposition of 13-HPODE was not affected by alpha-tocopherol, several other antioxidants, or antioxidant enzymes. Moreover, the inclusion of alpha-tocopherol during the decomposition of 13-HPODE resulted in an accumulation of aldehydes. Further oxidation of aldehydes to carboxylic acids by a number of oxidases was prevented by alpha-tocopherol. Conversely, the formation of carboxylic acids may be conducive to plaque stabilization via immunomodulation, rapid degradation, and by calcium sequestration. Thus, the inhibition of formation of carboxylic acids could be a serious deleterious effect of antioxidant treatment. In contrast, alpha-keto acids, like pyruvic acid, promoted the conversion of 13-HPODE to 13-hydroxylinoleic acid (13-HODE) by readily undergoing decarboxylation into acetate. These observations suggest that agents that promote the reduction of lipid peroxides into lipid hydroxides could be far more effective in treating cardiovascular diseases as opposed alpha-tocopherol-like antioxidants that could affect additional steps in the oxidation cascade.

Indexed as

Aldehydesalpha-TocopherolAntioxidantsAtherosclerosisCarboxylic AcidsChromatography, LiquidChromatography, Thin LayerHumansLinoleic AcidsLipid PeroxidesMass SpectrometryModels, BiologicalOxidation-ReductionPyruvic AcidSpectrophotometry, Infrared13-hydroperoxy-9,11-octadecadienoic acid13-hydroxylinoleic acidAldehydesalpha-TocopherolAntioxidantsCarboxylic AcidsLinoleic AcidsLipid PeroxidesPyruvic Acid

Identifiers

PMID19186999
PMCPMC2842134
OpenAlexW1969881609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.